The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain

Neuroscience

Volumn 73, Issue 2, 1996, Pages 531-540

  Burnet, P W J ^a,b   Chen, C P L H ^b   McGowan, S ^a   Franklin, M ^c   Harrison, P J ^a,b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c Littlemore Mental Health Centre   (United Kingdom)

Author keywords

5 hydroxytryptamine; antipsychotic; mRNA; neuroleptic; schizophrenia; serot onin

Indexed keywords

CLOZAPINE; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; FOREBRAIN; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SCHIZOPHRENIA; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM;

EID: 0029891621     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00062-0     Document Type: Article

References (70)

1. Akiyoshi J., Hough C. and Chuang D.-M. (1993) Paradoxical increase of 5-hydroxytryptamine, receptors and 5-hydroxytryptamine, receptor mRNA in cerebellar granule cells after persistent 5-hydroxytryptamine, receptor simulation. Molec. Pharmac. 43, 349-355.
2. 2 receptors in rat cerebral cortex. J. Neurochem. 46, 191-197.
3. Andres A. H., Rao M. L., Ostrowitzki S. and Entzian W. (1993) Human brain cortex and platelet serotonin-2-receptor binding properties and their regulation by endogenous serotonin. Life Sci. 52, 313-321.
4. Arora R. C. and Meltzer H. Y. (1994) Effect of clozapine treatment on serotonin-2 receptor binding in the blood platelets of schizophrenic patients. Neuropsychopharmacology 10, 109-114.
5. 2A receptor gene. Lancet 346, 281-282.
6. 2 receptors in the medial prefrontal cortex: microiontophoretic studies. Brain Res. 506, 346-348.
7. Baldessarini R. J., Huston-Lyons D., Campbell A., Marsh E. and Cohen B. M. (1992) Do central anti-adrenergic actions contribute to the atypical properties of clozapine? Br. J. Psychiat. 160, Suppl. 17, 12-16.
8. 1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Molec. Pharmac. 44, 725-730.
9. 2 receptor subtypes: a family re-united? Trends pharmac. Sci. 105, 105-110.
10. Blackshear M. A., Friedman R. L. and Sanders-Bush E. (1983) Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn-Schmiederberg's Arch. Pharmac. 324, 125-129.
11. Breier A. (1995) Serotonin, schizophrenia and antipsychotic drug action. Schizophr. Res. 14, 187-202.
12. 2 receptors. Life Sci. 42, 2439-2445.
13. Bürki H. R., Ruch W. and Asper H. (1975) Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat. Psychopharmacologia, Berlin 41, 27-33.
14. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology (in press).
15. 2A receptor mRNA in human brain. Brain Res. 676, 157-168.
16. 2A receptor expression. NeuroReport 6, 901-904.
17. 1A receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res. 638, 311-324.
18. 2 receptor mRNA in rat frontal cortex. J. Neurochem. 61, 1270-1276.
19. 2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. Neurosci. Lett. 181, 65-68.
20. 1A binding in rat brain - a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561, 51-60.
21. 2A receptor. J. Neurochem. 63, 465-469.
22. Creese I., Burt D. R. and Snyder S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs. Science 192, 481-483.
23. Csernansky J. G., Wrona C. T., Bardgett M. E., Early T. S. and Newcomer J. W. (1993) Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacologia 110, 145-151.
24. Curtis V. A., Wright P., Reveley A., Kerwin R. and Lucey J. V. (1995) Effect of clozapine on D-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. Br. J. Psychiat. 166, 642-646.
25. Deutch A. Y., Moghaddam B., Innis R. B., Krystal J. H., Aghajanian G. K., Bunney B. S. and Charney D. S. (1991) Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia. Schizophr. Res. 4, 121-156.
26. Farde L., Nordstron A. L., Nyberg S., Halldin C. and Sedvall G. (1994) D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. J. clin. Psychiat. 55, suppl B, 67-69.
27. 2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J. biol. Chem. 269, 31850-31857.
28. Gallager D. W. and Aghajanian G. K. (1976) Effect of antipsychotic drugs on the firing of dorsal raphe cells. I. Role of adrenergic systems. Eur. J. Pharmac. 39, 341-355.
29. 2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs. Neuroscience 58, 515-525.
30. 1C receptor mRNA in adult rat brain. Fedn Eur. biochem. Socs Lett. 247, 453-462.
31. Julius D., MacDermott A. B., Axel R. and Jessell T. M. (1987) Molecular characterization of a functional cDNA encoding the serotonin Ic receptor. Science 241, 558-564.
32. Kahn R. S. Davidson M. Siever L., Gabriel S., Apter S. and Davis K. L. (1993) Serotonin function and treatment response to clozapine in schizophrenic patients. Am J. Psychiat. 150, 1337-1342.
33. Kerwin R. W. (1994) The new atypical antipsychotics. Br. J. Psychiat. 164, 141-148.
34. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13, 139-150.
35. Kuoppomäki M., Seppala T., Syvalähti E. and Hietala J. (1993) Chronic clozapine treatment decreases 5-hydroxytryptamine 1C receptor density in rat choroid plexus: comparison with haloperidol. J. Pharmac. exp. Ther. 264, 1262-1267.
36. Lappalainen J., Hietala J., Koulu, M. and Syvalahti E. (1990) Neurochemical effects of chronic co-administration of ritanserin and haloperidol: comparison with clozapine effects. Eur. J. Pharmac. 190, 403-407.
37. 2) receptor numbers in the rat brain. Psychiat. Res. 12, 277-285.
38. 1A receptors. Eur. J. Pharmac. 260, 79-83.
39. 2 receptors. Psychopharmacologia 112, S40-S54.
40. Lidow M. S., Birnbaum S. G. and Goldman-Rakic P. S. (1995) Clozapine, haloperidol and remoxipride differentially regulate 5-HT2-serotonergic sites in the primate cerebral cortex (abstract). Schizophr. Res. 15, 158.
41. Lowry O., Rosebrough N., Farr A. and Randall R. (1951) Protein measurement with the Folin phenol reagent. J. biol. Chem. 193, 265-270.
42. MacGibbon G. A., Lawlor P. A., Bravo R. and Dragunow M. (1994) Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Molec. Brain Res. 23, 21-32.
43. 1A receptors in human brain tissue. Eur. J. Pharmac. 221, 397-398.
44. Matsubara S. and Meltzer H. Y. (1989) Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. Life Sci. 45, 1397-1406.
45. 2 receptors in rat brain. Neuropsychopharmacology 2, 81-87.
46. Meltzer H. Y. and Nash J. F. (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmac Rev. 43, 587-604.
47. Merchant K. M., Dobner P. M. and Dorsa D. M. (1992) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J. Neurosci. 12, 652-663.
48. Mikuni M. and Meltzer H. Y. (1984) Reduction of serotonin, receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof. Life Sci. 34, 87-92.
49. Molineaux S. M., Jessell T. M., Axel R. and Julius D. (1989) 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. natn. Acad. Sci. U.S.A. 86, 6793-6797.
50. 2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics? J. Psychopharmac. 8, 193-195.
51. O'Dell S. J., La Hoste G. J., Widmark C. B., Shapiro R. M., Potkin S. G. and Marshall J. F. (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6, 146-153.
52. Ostrowitzki S., Rao M. L., Rédei J. and Andres A. H. (1993) Concurrence of cortex and platelet serotonin-2-receptor binding characteristics in the individual and the putative regulation by serotonin. J. neural Transm. (Gen. Sect.) 93, 27-35.
53. 2C receptors. Molec. Brain Res. 23, 163-178.
54. 2 receptor desensitization. Eur. J. Pharmac. 238, 173-180.
55. 2 receptors. Eur. J. Pharmac. 89, 325-326.
56. 2 receptor antagonist. Eur. J. Pharmac. molec. Pharmac. 246, 73-80.
57. Robertson G. S. and Fibiger H. C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46, 315-328.
58. 2 receptor mRNA levels. Eur. J. Pharmac. molec. Pharmac. 207, 169-172.
59. Roth B. L., Ciaranello R. D. and Meltzer H. Y. (1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J. Pharmac. exp. Ther. 260, 1361-1365.
60. Roth B. L., Craigo S. C., Choudhary M. S., Uluer A., Monsma F. J. Jr, Shen Y., Meltzer H. Y. and Sibley D. R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmac. exp. Ther. 268, 1403-1410.
61. 1C serotonin receptor levels. Methodology and mechanisms. Neuropsychopharmacology 3, 427-433.
62. 2A receptors in antipsychotic activity. Life Sci. 56, 2209-2222.
63. 3) as a novel target for antipsychotics. Biochem. Pharmac. 43, 659-666.
64. Stockmeier C. A., DiCarlo J. J., Zhang Y., Thompson P. and Meltzer H. Y. (1993) Characterization of typical and atypical antipsychotic drugs based on in vitro occupancy of serotonin, and dopamine, receptors. J. Pharmac. exp. Ther. 266, 1374-1394.
65. 1,2 and serotonin, receptor binding of antipsychotics in vivo. Pharmac. Biochem. Behav. 49, 165-169.
66. Toth M. and Shenk T. (1994) Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2-receptor gene expression: modulation of transcription. Molec. Pharmac. 45, 1095-1100.
67. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-614.
68. Vincent S. L., McSparren J., Wang R. Y. and Benes F. M. (1991) Evidence for ultrastructural changes in cortical axodendritic synapses following long-term treatment with haloperidol or clozapine. Neuropsychopharmacology 5, 147-155.
69. 2) receptors in the rat brain. Brain Res. 487, 288-298.
70. Yamamoto B. K., Pehek E. A. and Meltzer H. Y. (1994) Brain region effects of clozapine on amino acid and monoamine transmission. J. clin. Psychiat. 55, Suppl B, 8-14.